|Articles|February 10, 2021
Using Optimized Protocols and Easy Automation to Advance N-Glycan Analysis of Next-Generation Biotherapeutics
Author(s)Waters
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
4
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
5
